Evaluating the role of active TGF-β1 as inflammatory biomarker in Kashmiri (North-Indian) patients with systemic sclerosis: a case-control study
In patients with SSc, elevated levels of TGF-β1 in serum and their correlation with clinical symptoms imply that this cytokine may serve as a marker for fibrotic and vascular involvement in SSc.
Authors
- Sakeena Ayub
- Nawaf Alshammari (ORCID: https://orcid.org/0000-0001-7975-4427)
- Zafar A. Shah (ORCID: https://orcid.org/0000-0001-9269-9303)
- Ayaz Gull (ORCID: https://orcid.org/0000-0003-2913-8022)
- Mοhd Saeed (ORCID: https://orcid.org/0000-0003-3443-386X)
- Muzaffar Bindroo
- Tabasum Shafi
- Roohi Rasool
- Mushtaq Dangroo
- Lamya A. Alkeridis
Institutions
- Princess Nourah bint Abdulrahman University (SA)
- Sher-i-Kashmir Institute of Medical Sciences (IN)
- University of Ha'il (SA)
Publication Details
- Journal
- Advances in Rheumatology
- Published
- 2024-12-23
- DOI
- https://doi.org/10.1186/s42358-024-00433-4
- Citations
- 1
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- Princess Nourah Bint Abdulrahman University